Mild COVID-19 in ANCA-associated vasculitis treated with rituximab
Open Access
- 7 August 2020
- journal article
- letter
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 80 (6), e99
- https://doi.org/10.1136/annrheumdis-2020-218246
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumoniaAnnals Of The Rheumatic Diseases, 2020
- Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19Annals Of The Rheumatic Diseases, 2020
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapiesAnnals Of The Rheumatic Diseases, 2020
- Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendationsRMD Open, 2019
- The Biology of CD20 and Its Potential as a Target for mAb TherapyCurrent directions in autoimmunity, 2004